Session Information
Free - Current Quandaries and Advances in Fracture Prediction and Osteoporosis Therapy
Click here to go to the previous page
Role of RANK-L in Skeletal Metabolism & Osteoporosis Treatment
Track
:
Current Quandaries and Advances in Fracture Prediction and Osteoporosis Therapy
Program Code:
390-3
Date:
Sunday, June 20, 2010
Time:
6:30 PM to 9:30 PM
EST
DIRECTOR
:
Dennis M. Black, PhD, UCSF
SPEAKER
:
John P. Bilezikian, MD, Columbia Univ Coll of Phys & Surg
Disclosure: has received consulting fees from Eli Lilly, Novartis, Alliance for Better Bone Health, NPS Pharmaceuticals, Merck and Amgen and speaker fees from Eli Lilly, Novartis, and the Alliance for Better Bone Health.
Disclosure: has received consulting fees from Eli Lilly, Novartis, Alliance for Better Bone Health, NPS Pharmaceuticals, Merck and Amgen and speaker fees from Eli Lilly, Novartis, and the Alliance for Better Bone Health.
Audio Synchronized to PowerPoint
